Table 1.

Comparative Analysis of Giant Cell Arteritis Mortality Studies to Date

Study	Year	Number of Patients	Percent Biopsy Proven	Primary Method of Analysis	Unit Time	Findings
Hauser and colleagues (19)	1971	19	63	Life table	y	No effect
Huston and colleagues (8)	1978	42	90	Kaplan-Meier	mo	No effect
Jonasson and colleagues (20)	1979	136	100	Standardized mortality ratio	mo	No effect
Graham and colleagues (21)	1981	90	100	Life table	mo	Increased mortality in women
Chuang and colleagues (22)	1982	15	93	Kaplan-Meier	mo	No effect
Gouet and colleagues (23)	1985	87	100	Life table	y	No effect
Andersson and colleagues (24)	1986	90	72	Standardized mortality ratio	mo	Increased 5-y survival, no  effect at 10 and 15 y
Nordborg and Bengtsson (18)	1989	284	100	Standardized mortality ratio	mo	No effect
Bisgård and colleagues (25)	1991	34	100	Standardized mortality ratio	y	Increased mortality
Nesher and colleagues (26)	1994	43	91	Standardized mortality ratio	mo	Increased mortality
Matteson and colleagues (27)	1996	205	Not reported (<100)	Standardized mortality ratio	d	No effect
García-Porrúa and colleagues (28)	1996	54	100	Standardized mortality ratio	mo	Increased mortality at 5 y, no  effect at 10 y
González-Gay and colleagues (29)	1997	109	100	Standardized mortality ratio	mo	No effect
Gran and colleagues (30)	2001	42	100	Cox proportional hazard	mo	No effect
Uddhammar and colleagues (31)	2002	136	100	Standardized mortality ratio	d	Increased mortality in women
Salvarani and colleagues (32)	2004	173	87	Kaplan-Meier	d	No effect
Crow and colleagues	2007	44	100	Kaplan-Meier	d	Increased mortality at 5 y

Note: d = days; mo = months; y = years.